Effects of metformin on ischemic stroke’s clinical feature in non-diabetic patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N73

Enrollment

Registered

2018-03-14

Start date

2016-07-18

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke. Brain stem stroke syndrome

Interventions

Intervention 1: Intervention group: In intervention group, we treat patients with 500 milligram Metformin daily after breakfast ,24 hours after signs in 3 months. Intervention 2: Control group: In con

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Non-diabetic people Ischemic stroke

Exclusion criteria

Exclusion criteria: Death Non-ischemic stroke Patients with heart disease fixed Patients with drug addiction or drug abuse

Design outcomes

Primary

Measure	Time frame
Neurological clinical course. Timepoint: start and every month to 3 months after end of treatment. Method of measurement: National Institutes of Health Stroke Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohsen Ebrahimimonfared

Arak University of Medical Sciences

ebrahimimonfared@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026